RF Acquisition Corp II
Status: Live Deal
U=S+R R=S/20
IPO Proceeds, $M $115.00M
IPO Date May 17, 2024
CEO Tse Meng Ng
Left Lead EarlyBirdCapital
IPO Cash in Trust 100.5%
SPAC Tenor 18 months
IPO Sector Technology
IPO Geography Asia
Target Company Nanyang Biologics
Deal Announced Oct 2, 2025
Deal Size, $M TBD
Deal Sector Healthcare
Deal Geography Asia
SEC Filings www.sec.gov
Approval Vote TBD
Amendment Vote Nov 10, 2025
RFAI RFAIU RFAIR

Sign up for Free Trial

No credit card required

Sign in to view structure, cap table, and calendar of events.